• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

敲低CHCHD2可抑制人肾细胞癌的迁移和血管生成:一种治疗肾细胞癌的潜在分子标志物。

Knockdown of CHCHD2 inhibits migration and angiogenesis of human renal cell carcinoma: A potential molecular marker for treatment of RCC.

作者信息

Cheng Qian, Qu Debao, Lu Zheng, Zhang Longzhen

机构信息

Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu 221002, P.R. China.

Department of Radiation Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221002, P.R. China.

出版信息

Oncol Lett. 2019 Jan;17(1):765-772. doi: 10.3892/ol.2018.9686. Epub 2018 Nov 12.

DOI:10.3892/ol.2018.9686
PMID:30655828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6313053/
Abstract

Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 (CHCHD2), a novel cell migration determinant, is able to co-express with other genes of the oxidative phosphorylation pathway by using a computational expression screening technique. However, little is known about the expression and biological function of CHCHD2 in human renal cell carcinoma (RCC). Western blotting was performed to detect CHCHD2 expression levels in normal renal cells and carcinoma cells. Immunohistochemistry was performed to detect an association between CHCHD2 expression and clinicopathological parameters in 75 RCC tissues using a tissue microarray. The function of CHCHD2 in the migration and angiogenesis of RCC cells was investigated using Transwell migration and tube formation assays. CHCHD2 expression was markedly increased in human RCC cells. The results of immunohistochemical analysis revealed that CHCHD2 expression was markedly associated with tumor grade (P<0.001). Notably, CHCHD2 knockdown inhibited RCC migration and tube formation of human umbilical vascular endothelial cells. CHCHD2 knockdown further suppressed matrix metalloproteinase-2 protein levels and enzyme activity. An ELISA identified that CHCHD2 knockdown decreased the secretion of vascular endothelial growth factor. The gathered data disclose information on the association of CHCHD2 with migration and angiogenesis of human RCC, and may strengthen the feasibility of targeting CHCHD2 as a potential therapeutic target.

摘要

含卷曲螺旋-螺旋-卷曲螺旋-螺旋结构域蛋白2(CHCHD2)是一种新型的细胞迁移决定因子,通过使用计算表达筛选技术,它能够与氧化磷酸化途径的其他基因共表达。然而,关于CHCHD2在人类肾细胞癌(RCC)中的表达和生物学功能知之甚少。进行蛋白质免疫印迹法检测正常肾细胞和癌细胞中CHCHD2的表达水平。使用组织芯片对75例RCC组织进行免疫组织化学检测,以检测CHCHD2表达与临床病理参数之间的关联。使用Transwell迁移实验和管腔形成实验研究CHCHD2在RCC细胞迁移和血管生成中的功能。CHCHD2在人类RCC细胞中的表达明显增加。免疫组织化学分析结果显示,CHCHD2表达与肿瘤分级显著相关(P<0.001)。值得注意的是,敲低CHCHD2可抑制RCC迁移以及人脐静脉血管内皮细胞的管腔形成。敲低CHCHD2进一步抑制基质金属蛋白酶-2的蛋白水平和酶活性。酶联免疫吸附测定法确定敲低CHCHD2可降低血管内皮生长因子的分泌。收集的数据揭示了CHCHD2与人类RCC迁移和血管生成之间的关联信息,并可能增强将CHCHD2作为潜在治疗靶点的可行性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb1/6313053/8803bebde2fb/ol-17-01-0765-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb1/6313053/875c5ecadd75/ol-17-01-0765-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb1/6313053/e96fbe697a56/ol-17-01-0765-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb1/6313053/2b3ff96a75a6/ol-17-01-0765-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb1/6313053/8803bebde2fb/ol-17-01-0765-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb1/6313053/875c5ecadd75/ol-17-01-0765-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb1/6313053/e96fbe697a56/ol-17-01-0765-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb1/6313053/2b3ff96a75a6/ol-17-01-0765-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb1/6313053/8803bebde2fb/ol-17-01-0765-g03.jpg

相似文献

1
Knockdown of CHCHD2 inhibits migration and angiogenesis of human renal cell carcinoma: A potential molecular marker for treatment of RCC.敲低CHCHD2可抑制人肾细胞癌的迁移和血管生成:一种治疗肾细胞癌的潜在分子标志物。
Oncol Lett. 2019 Jan;17(1):765-772. doi: 10.3892/ol.2018.9686. Epub 2018 Nov 12.
2
CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients.CHCHD2促进肝细胞癌发生,并提示肝细胞癌患者预后不良。
J Cancer. 2019 Nov 1;10(27):6822-6828. doi: 10.7150/jca.31158. eCollection 2019.
3
PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction.PD 相关的 CHCHD2 突变会损害 CHCHD10 和 MICOS 复合物,导致线粒体功能障碍。
Hum Mol Genet. 2019 Apr 1;28(7):1100-1116. doi: 10.1093/hmg/ddy413.
4
CHCHD2 Is Coamplified with EGFR in NSCLC and Regulates Mitochondrial Function and Cell Migration.CHCHD2在非小细胞肺癌中与EGFR共同扩增,并调节线粒体功能和细胞迁移。
Mol Cancer Res. 2015 Jul;13(7):1119-29. doi: 10.1158/1541-7786.MCR-14-0165-T. Epub 2015 Mar 17.
5
Identification of novel cell migration-promoting genes by a functional genetic screen.通过功能遗传筛选鉴定新型细胞迁移促进基因。
FASEB J. 2010 Feb;24(2):464-78. doi: 10.1096/fj.09-137562. Epub 2009 Oct 7.
6
Mitochondrial CHCHD2: Disease-Associated Mutations, Physiological Functions, and Current Animal Models.线粒体CHCHD2:疾病相关突变、生理功能及当前动物模型
Front Aging Neurosci. 2021 Apr 22;13:660843. doi: 10.3389/fnagi.2021.660843. eCollection 2021.
7
CHCHD2 is down-regulated in neuronal cells differentiated from iPS cells derived from patients with lissencephaly.在从无脑回畸形患者来源的诱导多能干细胞分化而来的神经细胞中,CHCHD2表达下调。
Genomics. 2015 Oct;106(4):196-203. doi: 10.1016/j.ygeno.2015.07.001. Epub 2015 Jul 15.
8
CHCHD2 harboring Parkinson's disease-linked T61I mutation precipitates inside mitochondria and induces precipitation of wild-type CHCHD2.携带有帕金森病相关 T61I 突变的 CHCHD2 在内质网中沉淀,并诱导野生型 CHCHD2 沉淀。
Hum Mol Genet. 2020 May 8;29(7):1096-1106. doi: 10.1093/hmg/ddaa028.
9
CHCHD10 is involved in the development of Parkinson's disease caused by CHCHD2 loss-of-function mutation p.T61I.CHCHD10 参与由 CHCHD2 功能丧失突变 p.T61I 引起的帕金森病的发病机制。
Neurobiol Aging. 2019 Mar;75:38-41. doi: 10.1016/j.neurobiolaging.2018.10.020. Epub 2018 Oct 23.
10
Decreased expression of CHIP leads to increased angiogenesis via VEGF-VEGFR2 pathway and poor prognosis in human renal cell carcinoma.CHIP表达降低通过VEGF-VEGFR2途径导致人肾细胞癌血管生成增加及预后不良。
Sci Rep. 2015 May 29;5:9774. doi: 10.1038/srep09774.

引用本文的文献

1
Effect of periplocin on malignant behavior of oral squamous cell carcinoma cells.杠柳毒苷对口腔鳞状细胞癌细胞恶性行为的影响。
Transl Cancer Res. 2025 May 30;14(5):2722-2736. doi: 10.21037/tcr-24-2025. Epub 2025 May 27.
2
CHCHD2 mediates glioblastoma cell proliferation, mitochondrial metabolism, hypoxia‑induced invasion and therapeutic resistance.CHCHD2 介导脑胶质母细胞瘤细胞增殖、线粒体代谢、缺氧诱导侵袭和治疗抵抗。
Int J Oncol. 2023 Nov;63(5). doi: 10.3892/ijo.2023.5565. Epub 2023 Sep 1.
3
Increased CHCHD2 expression promotes liver fibrosis in nonalcoholic steatohepatitis via Notch/osteopontin signaling.

本文引用的文献

1
CHCHD2 inhibits apoptosis by interacting with Bcl-x L to regulate Bax activation.CHCHD2通过与Bcl-x L相互作用来调节Bax激活,从而抑制细胞凋亡。
Cell Death Differ. 2015 Jun;22(6):1035-46. doi: 10.1038/cdd.2014.194. Epub 2014 Dec 5.
2
MNRR1 (formerly CHCHD2) is a bi-organellar regulator of mitochondrial metabolism.MNRR1(原名CHCHD2)是线粒体代谢的双细胞器调节因子。
Mitochondrion. 2015 Jan;20:43-51. doi: 10.1016/j.mito.2014.10.003. Epub 2014 Oct 12.
3
Oxygen-dependent expression of cytochrome c oxidase subunit 4-2 gene expression is mediated by transcription factors RBPJ, CXXC5 and CHCHD2.
CHCHD2 表达增加通过 Notch/骨桥蛋白信号促进非酒精性脂肪性肝炎肝纤维化。
JCI Insight. 2022 Dec 8;7(23):e162402. doi: 10.1172/jci.insight.162402.
4
CHCHD2 Regulates Mitochondrial Function and Apoptosis of Ectopic Endometrial Stromal Cells in the Pathogenesis of Endometriosis.CHCHD2 调控在位子宫内膜间质细胞的线粒体功能和凋亡在子宫内膜异位症发病机制中的作用。
Reprod Sci. 2022 Aug;29(8):2152-2164. doi: 10.1007/s43032-021-00831-9. Epub 2022 Feb 14.
5
COX4I2 is a novel biomarker of blood supply in adrenal tumors.COX4I2是肾上腺肿瘤血液供应的一种新型生物标志物。
Transl Androl Urol. 2021 Jul;10(7):2899-2909. doi: 10.21037/tau-21-229.
6
Potential prognostic biomarkers related to immunity in clear cell renal cell carcinoma using bioinformatic strategy.基于生物信息学策略的透明细胞肾细胞癌相关免疫预后生物标志物。
Bioengineered. 2021 Dec;12(1):1773-1790. doi: 10.1080/21655979.2021.1924546.
7
CHCHD2: The Power House's Potential Prognostic Factor for Cancer?CHCHD2:癌症潜在的预后因素——细胞动力工厂?
Front Cell Dev Biol. 2021 Jan 12;8:620816. doi: 10.3389/fcell.2020.620816. eCollection 2020.
氧依赖型细胞色素 c 氧化酶亚基 4-2 基因表达的调控是由转录因子 RBPJ、CXXC5 和 CHCHD2 介导的。
Nucleic Acids Res. 2013 Feb 1;41(4):2255-66. doi: 10.1093/nar/gks1454. Epub 2013 Jan 8.
4
MicroRNAs in renal cell carcinoma: implications for pathogenesis, diagnosis, prognosis and therapy.微小 RNA 在肾细胞癌中的作用:对发病机制、诊断、预后和治疗的影响。
Anticancer Res. 2012 Sep;32(9):3727-32.
5
Early transcriptional changes linked to naturally occurring Huntington's disease mutations in neural derivatives of human embryonic stem cells.与人类胚胎干细胞的神经衍生物中自然发生的亨廷顿病突变相关的早期转录变化。
Hum Mol Genet. 2012 Sep 1;21(17):3883-95. doi: 10.1093/hmg/dds216. Epub 2012 Jun 7.
6
BRG1 expression is increased in human glioma and controls glioma cell proliferation, migration and invasion in vitro.BRG1 表达在人神经胶质瘤中增加,并控制体外神经胶质瘤细胞的增殖、迁移和侵袭。
J Cancer Res Clin Oncol. 2012 Jun;138(6):991-8. doi: 10.1007/s00432-012-1172-8. Epub 2012 Feb 24.
7
MMP-2 siRNA inhibits radiation-enhanced invasiveness in glioma cells.MMP-2 siRNA 抑制胶质瘤细胞的放射增强侵袭性。
PLoS One. 2011;6(6):e20614. doi: 10.1371/journal.pone.0020614. Epub 2011 Jun 16.
8
Epidemiology and risk factors for kidney cancer.肾癌的流行病学和危险因素。
Nat Rev Urol. 2010 May;7(5):245-57. doi: 10.1038/nrurol.2010.46.
9
Prognostic factors in renal cell carcinoma.肾细胞癌的预后因素。
World J Urol. 2010 Jun;28(3):319-27. doi: 10.1007/s00345-010-0540-8. Epub 2010 Apr 3.
10
Recent updates in renal cell carcinoma.肾细胞癌的最新进展。
Curr Opin Oncol. 2010 May;22(3):250-6. doi: 10.1097/CCO.0b013e328337a5d2.